Chordate Medical (Sweden) Price Prediction
| CMH Stock | 18.05 0.80 4.24% |
Oversold Vs Overbought
31
Oversold | Overbought |
Using Chordate Medical hype-based prediction, you can estimate the value of Chordate Medical Holding from the perspective of Chordate Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Chordate Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Chordate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Chordate Medical after-hype prediction price | SEK 18.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chordate |
Chordate Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Chordate Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chordate Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Chordate Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Chordate Medical Estimiated After-Hype Price Volatility
In the context of predicting Chordate Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chordate Medical's historical news coverage. Chordate Medical's after-hype downside and upside margins for the prediction period are 13.15 and 24.55, respectively. We have considered Chordate Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Chordate Medical is somewhat reliable at this time. Analysis and calculation of next after-hype price of Chordate Medical Holding is based on 3 months time horizon.
Chordate Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Chordate Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chordate Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chordate Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 5.67 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
18.05 | 18.85 | 0.00 |
|
Chordate Medical Hype Timeline
Chordate Medical Holding is currently traded for 18.05on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Chordate is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.31%. %. The volatility of related hype on Chordate Medical is about 0.0%, with the expected price after the next announcement by competition of 18.05. About 40.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Chordate Medical Holding had not issued any dividends in recent years. The entity had 500:1 split on the 29th of August 2024. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Chordate Medical Basic Forecasting Models to cross-verify your projections.Chordate Medical Related Hype Analysis
Having access to credible news sources related to Chordate Medical's direct competition is more important than ever and may enhance your ability to predict Chordate Medical's future price movements. Getting to know how Chordate Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chordate Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| XVIVO | Xvivo Perfusion AB | 0.00 | 0 per month | 0.00 | (0.12) | 3.00 | (3.34) | 12.19 | |
| BICO | BICO Group AB | 0.00 | 0 per month | 0.00 | (0.1) | 5.43 | (5.40) | 33.23 | |
| BACTI-B | Bactiguard Holding AB | 0.00 | 0 per month | 0.00 | (0.36) | 2.96 | (7.41) | 14.83 | |
| STIL | Stille AB | 0.00 | 0 per month | 1.78 | (0.01) | 4.27 | (2.83) | 15.04 | |
| SPEC | SpectraCure AB | 0.00 | 0 per month | 0.00 | (0.17) | 6.10 | (6.06) | 30.03 | |
| EPIS-B | Episurf Medical AB | 0.00 | 0 per month | 0.00 | (0.08) | 7.69 | (7.14) | 24.26 |
Chordate Medical Additional Predictive Modules
Most predictive techniques to examine Chordate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chordate using various technical indicators. When you analyze Chordate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Chordate Medical Predictive Indicators
The successful prediction of Chordate Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chordate Medical Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chordate Medical based on analysis of Chordate Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chordate Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chordate Medical's related companies.
Story Coverage note for Chordate Medical
The number of cover stories for Chordate Medical depends on current market conditions and Chordate Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chordate Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chordate Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Chordate Medical Short Properties
Chordate Medical's future price predictability will typically decrease when Chordate Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chordate Medical Holding often depends not only on the future outlook of the potential Chordate Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chordate Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 61.1 M | |
| Cash And Short Term Investments | 15.5 M |
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.